Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post-Transplant Complications

Recombinant tissue plasminogen activator for treatment of hepatic veno-occlusive disease following bone marrow transplantation in children: effectiveness and a scoring system for initiating treatment

Bone Marrow Transplantation volume 31, pages 591–597 (2003)Cite this article

Summary:

Hepatic veno-occlusive disease (HVOD) following bone marrow transplantation is potentially fatal. Criteria for diagnosis and starting treatment are mainly based on adult studies. Recombinant tissue plasminogen activator (rtPA) has been used with variable success. rtPA and heparin were given to 12 children (nine with immunodeficiency, two malignancy, one thalassaemia) with moderate to severe HVOD. Of the 12, 10 responded with a fall in bilirubin concentration; eight survived with complete resolution of HVOD. Four of the five patients with associated multiorgan failure (MOF) died despite rtPA treatment. One child suffered significant, and one minor, bleeding during rtPA treatment. A scoring system for quantifying the severity of HVOD in children is proposed, incorporating the criteria used to diagnose HVOD, risk factors for its development and also parameters reflective of the patient's general condition. This will facilitate early diagnosis and management of those cases which, if not treated promptly, are likely to deteriorate with an adverse outcome. Our experience suggests rtPA and heparin are an effective treatment for HVOD in children, with relatively little toxicity provided therapy is started before MOF develops.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Watanabe K, Iwaki H, Satoh M et al. Veno-occlusive disease of the liver following bone marrow transplantation: a clinical-pathological study of autopsy cases. Artif Organs 1996; 20: 1145–1150.

    Article  CAS  Google Scholar 

  2. Lee J-H, Lee K-H, Kim S et al. Relevance of proteins C and S, antithrombin III, Von Willebrand factor, and factor VIII for the development of hepatic veno-occlusive disease in patients undergoing allogeneic bone marrow transplantation: a prospective study. Bone Marrow Transplant 1998; 22: 883–888.

    Article  CAS  Google Scholar 

  3. Bearman SI, Anderson GL, Mori M et al. Venoocclusive disease of the liver: development of a model for predicting fatal outcome after marrow transplantation. J Clin Oncol 1993; 11: 1729–1736.

    Article  CAS  Google Scholar 

  4. McDonald GB, Hinds MS, Fisher LD et al. Veno-occlusive disease of the liver and multi organ failure after bone marrow transplantation – a cohort study of 355 patients. Ann Intern Med 1993; 118: 255–267.

    Article  CAS  Google Scholar 

  5. Kulkarni S, Rodriguez M, Lafuente A et al. Recombinant tissue plasminogen activator (rtPA) for the treatment of hepatic veno-occlusive disease (HVOD). Bone Marrow Transplant 1999; 23: 803–807.

    Article  CAS  Google Scholar 

  6. Richardson P, Elais ED, Krishnan A et al. Treatment of severe Veno-occlusive disease with defibrotide: compassionate use results in response without significant toxicity in a high risk population. Blood 1998; 92: 737–744.

    CAS  Google Scholar 

  7. Miniero R, Vassallo E, Soldano S et al. Management of hepatic veno-occlusive disease in pediatric patients: retrospective analysis in 6 AIEOP-BMT (Italian Pediatric Hematolgy Oncology Association-Bone Marrow Transplantation group) centers. Bone Marrow Transplant 1996; 18(Suppl 2): 157–159.

    Google Scholar 

  8. Jones RJ, Lee KSK, Beschorer WE et al. Venocclusive disease of the liver following bone marrow transplantation. Transplantation 1987; 44: 778–783.

    Article  CAS  Google Scholar 

  9. Wilkinson JD, Pollack MM, Ruttimann UE et al. Outcome of pediatric patients with multiple organ system failure. Crit Care Med 1986; 14: 271–274.

    Article  CAS  Google Scholar 

  10. Nünberger W, Heying R, Burdach S et al. C1 esterase inhibitor concentrate for capillary leakage syndrome following bone marrow transplantation. Ann Hematol 1997; 75: 95–101.

    Article  Google Scholar 

  11. Schriber J, Milk B, Shaw D et al. Tissue plasminogen activator (tPA) as therapy for hepatotoxicity following bone marrow transplantation. Bone Marrow Transplant 1999; 24: 1311–1314.

    Article  CAS  Google Scholar 

  12. Bearman SI, Lee JL, Baron AE et al. Treatment of hepatic venoocclusive disease with recombinant human tissue plasminogen activator and heparin in 42 marrow transplant patients. Blood 1997; 89: 1501–1506.

    CAS  Google Scholar 

  13. Goyal RK, Wall DA, Yu LC et al. Identification of patients with hepatic venoocclusive disease likely to respond to rtPA therapy. Blood 1993; 10(Suppl 1): 632a (abstract).

    Google Scholar 

  14. McDonald GB, Sharma P, Matthews DE et al. Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence and predisposing factors. Hepatology 1984; 4: 116.

    Article  CAS  Google Scholar 

  15. Morris JD, Harris RE, Hashmi R et al. Anti-thrombin-III for the treatment of chemotherapy-induced organ dysfunction following bone marrow transplantation. Bone Marrow Transplant 1997; 20: 871–878.

    Article  CAS  Google Scholar 

  16. Eltumi M, Trivedi P, Hobbs JR et al. Monitoring of veno-occlusive disease after bone marrow transplantation by serum aminopropeptide of type III procollagen. Lancet 1993; 342: 518–521.

    Article  CAS  Google Scholar 

  17. Tanikawa S, Mori S, Ohhashi K et al. Predictive markers for hepatic veno-occlusive disease after hematopoietic stem cell transplantation in adults: a prospective single center study. Bone Marrow Transplant 2000; 26: 881–886.

    Article  CAS  Google Scholar 

  18. Salat C, Holler E, Wolf C et al. Laboratory markers of veno-occlusive disease in the course of bone marrow transplantation. Bone Marrow Transplant 1997; 19: 487–490.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Childrens Bone Marrow Transplant Unit, Newcastle General Hospital, Newcastle upon Tyne, NE4 6BE, UK

    R P S Bajwa, A J Cant, M Abinun, T J Flood & R Skinner

  2. Department of Paediatric Hepatology, Royal Victoria Infirmary, Newcastle upon Tyne, NE1 4LP, UK

    S Hodges

  3. Department of Paediatric Oncology, Royal Victoria Infirmary, Newcastle upon Tyne, NE1 4LP, UK

    J P Hale & R Skinner

Authors
  1. R P S Bajwa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A J Cant
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M Abinun
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. T J Flood
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S Hodges
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J P Hale
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. R Skinner
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bajwa, R., Cant, A., Abinun, M. et al. Recombinant tissue plasminogen activator for treatment of hepatic veno-occlusive disease following bone marrow transplantation in children: effectiveness and a scoring system for initiating treatment. Bone Marrow Transplant 31, 591–597 (2003). https://doi.org/10.1038/sj.bmt.1703881

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1703881

Keywords

This article is cited by

Search

Advanced search

Quick links